January 29, 2021: A new coronavirus vaccine known as Novavax, which is given in two doses, has shown 89.3% efficacy in large-scale UK trials.
The Novavax jab is the first to be effective in the trials against the new variant in the UK, the BBC’s medical editor Fergus Walsh said.
Prime Minister said the medicines regulator in the UK would now assess the vaccine.
The UK secured 60 million doses of the jab, which will be made in Stockton-on-Tees in north-east England.
The doses are expected to be delivered later this year if approved for use by the Medicines and Healthcare Products Regulatory Agency (MHRA), the government said.
The Phase 3 trials are looked at by a regulator, enrolled more than 15,000 people aged 18 to 84, and 27% were older than 65, US firm Novavax said.
Chief executive of Novavax, Stan Erck, said the UK trial results were “spectacular” and “as good as we could have hoped.” At the same time, the efficacy in South Africa was above the people’s expectations.
Health Secretary Matt Hancock said the Novavax vaccine would be “another weapon in our arsenal to beat this awful virus” if approved.
Hancock thanked researches and volunteers for taking part in the trials, “I’m proud the UK is at the forefront of another medical breakthrough,” he said.
According to the UK Novavax trial’s chief investigator, the clinical trial findings were enormously exciting because of the jab’s efficacy against the new variant of the disease.
Peter Openshaw, professor at Imperial College in London, said the findings that the vaccine gave high levels of protection in the UK part of the trial were “excellent” but that the lower level of protection seen in South Africa was “a concern.”
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
In an industry as competitive and fast-paced as Consumer Packaged Goods (CPG), standing out from the crowd requires innovation and adaptability. The cracks in the CPG supply chain were exposed long before the global pandemic struck, but the events of the past year only exacerbated the weaknesses.
Supply chain leaders, including VPs, often find themselves making bets with unknown financial consequences. Having started with largely infeasible plans generated by deterministic “one-number” planning systems, compounded by unexpected supply or demand disruptions, they are forced into last-minute adjustments to meet operational and financial goals.
Unsurprisingly, today’s supply chain faces numerous issues, including sustainability, technology, global economic and political instability, talent management, and supply chain resilience. Advanced forecasting algorithms and predictive analytics are used in supply chain management to help organizations of all sizes make better decisions by providing insights into what’s going on in their business at any given moment and predicting future trends.
Ensuring the right products are in the right place and at the right time is critical for companies also dealing with supply chain constraints and a high degree of variability. Uncertainty has become the name of the game and the only way to effectively optimize inventory through continuous, data-driven assessments, planning, and decision-making.
Food Huggers, a consumer brand that designs products to reduce waste at home, may be in an enviable position now but before they found Extensiv Order Manager, managing booming orders and staying on top of inventory was a huge operational challenge. The business has inventory spread across multiple geographically distributed warehouses, with orders received via multiple sales channels, including Shopify storefronts and Amazon.
By late 202, the alarm bells were just starting to ring. Researchers discovered that Russian spies had months earlier burrowed deep into the networks of several U.S. federal networks. The spies, working for Russia’s foreign intelligence service, had first targeted SolarWinds, an IT company whose software helps to remotely manage the networks of thousands of businesses, Fortune 500 organizations and federal government agencies.